Global Wealth Strategies & Associates V Tv Therapeutics Inc. Transaction History

Global Wealth Strategies & Associates

  • $304 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
BUY
$0.66 - $40.8 $0 - $0
0 New
0 $0

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0
View Full List

About vTv Therapeutics Inc.

VTVT Quotes by TradingView
  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.42B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Global Wealth Strategies & Associates Portfolio

Follow Global Wealth Strategies & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Strategies & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Strategies & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email